HHHao He

Hao He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hao He has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Dayong Jin

    Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Sydney, Australia

    3 shared publications
  • Gungun Lin

    Institute for Biomedical Materials & Devices School of Mathematical and Physical Sciences Faculty of Science University of Technology Sydney Sydney New South Wales Australia

    3 shared publications
  • Shihui Wen

    Institute for Biomedical Materials and Devices (IBMD), School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Sydney, Australia

    3 shared publications
  • Jiajia Zhou

    Institute for Biomedical Materials and Devices (IBMD), Faculty of Science, University of Technology Sydney, Sydney, New South Wales 2007, Australia

    2 shared publications
  • Baolei Liu

    Beihang University

    1 shared publication
  • Christopher B. Howard

    Centre for Personalized Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia

    1 shared publication

Latest Publications

  • Quantitative Lateral Flow Strip Sensor Using Highly Doped Upconversion Nanoparticles

    by Hao He, Baolei Liu, Shihui Wen, Jiayan Liao, Gungun Lin, Jiajia Zhou, Dayong Jin

    Paper-based lateral flow assays, though being low-cost and widely used for rapid in vitro diagnostics, are indicative and do not provide sufficient sensitivity for the detection and quantification of low abundant biomarkers for early stage cancer diagnosis. Here, we design a compact device to create a focused illumination spot with high irradiance, which activates a range of highly doped 50 nm upconversion nanoparticles (UCNPs) to produce orders of magnitude brighter emissions. The device employs a very low-cost laser diode, simplified excitation, and collection optics and permits a mobile phone camera to record the results. Using highly erbium ion (Er3+)-doped and thulium ion (Tm3+)-doped UCNPs as two independent reporters on two-color lateral flow strips, new records of limit of detection (LOD), 89 and 400 pg/mL, have been achieved for the ultrasensitive detection of prostate specific antigen (PSA) and ephrin type-A receptor 2 (EphA2) biomarkers, respectively, without crosstalk. The technique and device presented in this work suggests a broad scope of low-cost, rapid, and quantitative lateral flow assays in early detection of bioanalytes.


  • DNA-mediated anisotropic silica coating of upconversion nanoparticles

    by Wei Ren, Yingzhu Zhou, Shihui Wen, Hao He, Gungun Lin, Deming Liu, Dayong Jin

    We report a facile approach of using DNA molecules as switches to selectively activate silica coating onto specific facets of upconversion nanoparticles.


  • Bispecific Antibody-Functionalized Upconversion Nanoprobe

    by Hao He, Christopher B. Howard, Yinghui Chen, Shihui Wen, Gungun Lin, Jiajia Zhou, Kristofer James Thurecht, Dayong Jin

    Upconversion nanoparticles (UCNPs) are new optical probes for biological applications. To realize specific biomolecular recognition for diagnosis and imaging, the key lies in developing a stable and easy-to-use bioconjugation method for antibody modification. Current methods are not yet satisfactory regarding conjugation time, stability, and binding efficiency. Here we report a facile and high-yield approach based on a bispecific antibody (BsAb), free of chemical reaction steps. One end of the BsAb is designed to recognize methoxy polyethylene glycol (mPEG) coated UCNPs, and the other end of the BsAb is to recognize the cancer antigen biomarker. Through simple vortexing, BsAb-UCNP nanoprobes form within 30 min and show higher (up to 54%) association to the target than the traditional UCNP nanoprobes in the ELISA-like assay tests. We further demonstrate its successful binding to the cancer cells with high efficiency and specificity for background-free fluorescence imaging under near-infrared excitation. This method suggests a general approach broadly suitable for functionalizing a range of nanoparticles to specifically target biomolecules.